Top Markets
Coin of the day
Ocumension Therapeutics Ocumension Therapeutics

Ocumension Therapeutics

1477
주식 순위 #12971
Based in the People's Republic of China, Ocumension Therapeutics functions as a... Based in the People's Republic of China, Ocumension Therapeutics functions as a dedicated ophthalmic pharmaceutical platform. This company, along with its subsidiaries, is committed to the research, progression, and market introduction of therapeutic solutions for individuals with various eye conditions. Its extensive product offerings target treatments for disorders such as blepharitis, infectious and allergic conjunctivitis, dry eye syndrome, cataracts, glaucoma, ocular hypertension, post-surgical inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, corneal graft rejection, myopia, and optic neuritis. By December 31, 2021, Ocumension Therapeutics boasted a pipeline of 20 drug assets. The company, founded in 2017, maintains its headquarters in Suzhou, China.
주가
$0.66137861
시가총액
$531.70M
변동 (1일)
-2.45%
변동 (1년)
-42.12%
국가
CN
거래 Ocumension Therapeutics (1477)

카테고리

Ocumension Therapeutics (1477)의 주가 이력
최고 종가: $0.68 (2026-08-01 기준)

최저 종가: $4.11 (2020-07-01 기준)
Ocumension Therapeutics의 주가 이력 (2020 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -10.84%
2025 66.97%
2024 -28.81%
2023 -25.43%
2022 -45.72%
2021 -33.26%
2020 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.01 -13.08%
AU
$138.18 473.58%
US
$753.02 6.32%
CH